Yale Medicine School: LIVE-HCM Study - Insights on Hypertrophic Cardiomyopathy Management
May 19, 2023
May 19, 2023
NEW HAVEN, Connecticut, May 19 (TNSres) -- Yale School of Medicine issued the following news:
* * *
Vigorous intensity activities are safe for people diagnosed with a common genetic disorder.
* * *
The American College of Cardiology (ACC) Annual Scientific Session included a late-breaking clinical trial on the safety of vigorous exercise for individuals with hypertrophic cardiomyopathy (HCM). On Monday, March 6 at 11:00 a.m. CT, Rachel Lampert, . . .
* * *
Vigorous intensity activities are safe for people diagnosed with a common genetic disorder.
* * *
The American College of Cardiology (ACC) Annual Scientific Session included a late-breaking clinical trial on the safety of vigorous exercise for individuals with hypertrophic cardiomyopathy (HCM). On Monday, March 6 at 11:00 a.m. CT, Rachel Lampert, . . .